| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Alzheimers disease and mirna effects 0.5409326908225485 4.230421928416659 2.3325338919244487e-05 0.0138748850155241 0.0040774366490963 90 P21796,P49721,Q99436,Q9BVA1,P04350,Q08209,Q9NQC3,Q8NEB9,P45880,P48556,P16615,Q96IX5,O14641,P60900,P20618,Q9Y277,P28070,P28072,P68371,Q9BUF5,P12236,O00213,O95197,P07437,Q16186,Q13885,P28482,P31751,P28074 29 |
| Alzheimers disease 0.5372239374364702 4.151996903324116 3.295867227448568e-05 0.0195489617049016 0.0040774366490963 89 P21796,P49721,Q99436,Q9BVA1,P04350,Q08209,Q9NQC3,Q8NEB9,P45880,P48556,P16615,O14641,P60900,P20618,Q9Y277,P28070,P28072,P68371,Q9BUF5,P12236,O00213,O95197,P07437,Q16186,Q13885,P28482,P31751,P28074 28 |
| Pathogenic escherichia coli infection 0.682884115277904 3.137355531859645 0.0017047926527031 0.6401407268078 0.0249066048529074 23 P07437,Q13885,P68371,Q9BUF5,Q9BVA1 5 |
| Parkinubiquitin proteasomal system pathway 0.5835919378482335 3.053758508272189 0.0022599392041404 0.7421134541887253 0.0307659905290941 36 P07437,Q13885,P68371,Q9BUF5,Q9BVA1,P04350 6 |
| Sphingolipid metabolism in senescence 0.8015296095776074 2.992326030372268 0.0027686041396131 0.8099929008963359 0.0368531973250722 14 Q96G23,P04062,Q16739,Q13510,P28482,O15269,P78345,P16278,Q06136 9 |
| Sphingolipid metabolism integrated pathway 0.8361486616765564 2.6833523323530746 0.0072888156008401 0.9874995392299496 0.0740000092356484 9 Q96G23,P27544,Q13510,Q16739,O95470,Q06136,Q8N5B7 7 |
| Sphingolipid metabolism overview 0.8798256817069431 2.646992657183505 0.0081211116367678 0.9924363865167354 0.0810757645070659 8 Q96G23,Q16739,Q13510,O95470,Q06136 5 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6024039217873233 2.6247264844823417 0.0086718597475206 0.9945769549058644 0.0837813546574974 24 Q15392,Q14739,Q14534,Q16850,P35610,P37268,Q9UBM7,Q15800 8 |
| Ferroptosis 0.6024200620806508 2.5838556514557887 0.0097702676073427 0.9972084760152692 0.0928124648035809 23 Q9NZ45,P45880,Q9Y277,Q9UPY5,P37268,P16435,P09601,Q9UKU0 8 |
| Sphingolipid pathway 0.7804906232150955 2.5787265959672565 0.0099165237853575 0.9974448541675424 0.0928124648035809 11 Q96G23,Q16739,Q13510,O95470,Q06136 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8820980700211345 2.357751588177087 0.018385991828955 0.999985123263081 0.1573315586506297 6 Q16850,Q9UBM7,Q14739 3 |
| Mitochondrial complex iv assembly 0.6282471929304569 2.2019187947031553 0.0276710451253601 0.9999999498676536 0.2142101176777772 16 P14406,Q9Y2R0,Q8N8Q8,Q9Y241,Q7KZN9,P00403 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.932083589428396 2.198776686871656 0.0278938049730661 0.9999999562968468 0.2142101176777772 4 Q06136,Q16739,O95470 3 |
| Metapathway biotransformation phase i and ii 0.5506051510784802 2.1747041736392023 0.0296522919395187 0.9999999852258245 0.2205588926927326 22 Q6UW02,Q86UY6,Q99735,P07099,Q16850,Q8NCH0,P21964 7 |
| Endothelin pathways 0.7609839167535983 2.102160872635463 0.0355391860124869 0.9999999996141063 0.2475345630404614 8 P42892,P00403,P16615 3 |
| Eicosanoid synthesis 0.9332685968114468 2.0903969098637796 0.0365821602561649 0.9999999997981652 0.2518702757866985 3 P09960 1 |
| Glutathione metabolism 0.8168787689776992 2.0766665921875185 0.0378323420423194 0.999999999907274 0.252436867990632 6 O75874 1 |
| Congenital generalized lipodystrophy cgl 0.8283169533169574 2.0444736580616856 0.0409067771360676 0.9999999999863656 0.2634748333817688 2 P31751 1 |
| Ciliopathies 0.5646186273062229 1.963629308730412 0.0495730959559639 0.9999999999999408 0.3059856823725032 18 Q9UBB4,Q10713,Q7Z4L5,Q15555,Q13432 5 |
| Statin inhibition of cholesterol production 0.870313460356485 1.9499267066614716 0.0511848554575002 0.9999999999999786 0.3096942264549764 4 P37268,P35610,Q8WTV0 3 |
| Nuclear receptors in lipid metabolism and toxicity 0.7991400491400573 1.9139947146868583 0.0556208310820993 0.9999999999999988 0.3298700774076982 2 P08183 1 |
| Ketogenesis and ketolysis 0.7746327805294687 1.890192387757457 0.0587322344000216 0.9999999999999998 0.3305610451192038 6 O43772,P53985,P23786 3 |
| Mitochondrial complex iii assembly 0.6744016041982511 1.8861936828368169 0.0592688594957813 1.0 0.3305610451192038 9 Q9UDW1,O14949 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.6044991303453885 1.882295173018941 0.0597959495376856 1.0 0.3305610451192038 14 O43772,Q16836,P23786 3 |
| Vitamin d metabolism 0.8792626728110585 1.875754205653284 0.0606890388735235 1.0 0.3305610451192038 3 P04062,Q9UBM7 2 |
| Cholesterol biosynthesis pathway 0.632072747188427 1.8716438938651323 0.0612558864912047 1.0 0.3305610451192038 12 P37268,Q16850,Q9UBM7,Q15800 4 |
| Nephrotic syndrome 0.6152676894824762 1.857554222805355 0.0632323443638378 1.0 0.3351873829552112 13 Q7Z4L5,O75844,Q14108 3 |
| Kennedy pathway from sphingolipids 0.7512445705751323 1.785561477391545 0.0741702889381461 1.0 0.3702333589495795 6 O95470,Q9UG56,Q9HBU6 3 |
| Familial hyperlipidemia type 4 0.760442260442265 1.7389332565571758 0.0820465036327351 1.0 0.3995598022439702 2 Q9UBV2 1 |
| Electron transport chain oxphos system in mitochondria 0.4083854745272948 1.6889213895909456 0.0912344956247346 1.0 0.4217830962122212 52 P24539,O75964,O75306,P14406,P13073,Q9Y6M9,O14949,Q9UDW1,O43676,Q7KZN9,P03886,P00403,O75880,P12236,O96000 15 |
| Drug induction of bile acid pathway 0.7450859950860066 1.6689126490431032 0.09513469242007 1.0 0.4217830962122212 2 P08183 1 |
| Influence of laminopathies on wnt signaling 0.6086927319202383 1.6673037627801832 0.095454018828236 1.0 0.4217830962122212 11 P50402,O75844,O60725 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.8013279054414133 1.6655686407702903 0.0957993614654713 1.0 0.4217830962122212 4 P09601,Q9UPY5 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5413879889339004 1.6517821032492284 0.0985789783171222 1.0 0.4217830962122212 16 P50402,O75844,P42167,O60725 4 |
| Proteoglycan biosynthesis 0.7974748424297267 1.6495137643838125 0.0990424256649529 1.0 0.4217830962122212 4 Q8NCH0 1 |
| Cytosine methylation 0.751938998699015 1.6446198828305925 0.1000482239686006 1.0 0.4217830962122212 5 O75874 1 |
| Familial partial lipodystrophy fpld 0.6636981128486605 1.6318591122817143 0.1027091692006179 1.0 0.4217830962122212 8 O75844,O60725 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.7343366093366195 1.61973981506717 0.1052881795733988 1.0 0.4217830962122212 2 O94826 1 |
| Sars coronavirus and innate immunity 0.7343366093366066 1.6197398150671112 0.1052881795734115 1.0 0.4217830962122212 2 P42224 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7457731324930916 1.6175855848649348 0.1057519377366511 1.0 0.4217830962122212 5 Q16539,P48507,P07099,P09601 4 |
| Nad biosynthetic pathways 0.7891326282818263 1.6146999398538793 0.1063756905892949 1.0 0.4217830962122212 4 P43490 1 |
| Nad metabolism 0.7891326282818263 1.6146999398538793 0.1063756905892949 1.0 0.4217830962122212 4 P43490 1 |
| Cannabinoid receptor signaling 0.7132312598615362 1.6135919265777905 0.1066159691769106 1.0 0.4217830962122212 6 Q8NCG7,P10644,P28482 3 |
| Glycosaminoglycan degradation 0.7124994202405218 1.6102600635955209 0.1073410938192263 1.0 0.4217830962122212 6 P08236,P16278 2 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7880193374370166 1.6100485790730503 0.1073872514362717 1.0 0.4217830962122212 4 Q8NEB9 1 |
| Vitamin d receptor pathway 0.5833537746108577 1.5946933664363352 0.1107808221746635 1.0 0.4281142740814417 12 P11413,P08183 2 |
| Estrogen receptor pathway 0.7251228501228606 1.5775001137762736 0.1146804959449325 1.0 0.4342647284377274 2 Q15067 1 |
| Cell differentiation expanded index 0.7251228501228526 1.5775001137762368 0.114680495944941 1.0 0.4342647284377274 2 Q15910 1 |
| Genes related to primary cilium development based on crispr 0.5657818385190088 1.5667822798504747 0.1171655907150692 1.0 0.4375934415310623 13 O95684,Q10713,Q7Z4L5,Q9Y496,A0AVF1,Q8WXW3 6 |
| Triacylglyceride synthesis 0.775770796627191 1.5587955124126296 0.1190447866962309 1.0 0.4396115665457227 4 Q9NUQ2,O00116 2 |
| Nonalcoholic fatty liver disease 0.3916828998563631 1.4981922017571498 0.1340833211415297 1.0 0.4809604320572185 50 Q9P0J0,O75306,P14406,Q86Y39,Q9Y6M9,Q9UDW1,P31751,O43676,P00403,O14949,O96000 11 |
| Spinal cord injury 0.4591563425485718 1.485537982973423 0.1374013694735754 1.0 0.4855475401599914 22 Q9NQC3,P11802,P28482,O43524,P14174,Q08209 6 |
| S1p receptor signal transduction 0.6676331116261742 1.4732209341111715 0.1406914721018204 1.0 0.4928315309297685 7 P31751,Q13510 2 |
| Nanomaterial induced apoptosis 0.7101137411620148 1.460415167254724 0.1441760068143827 1.0 0.4956833065299187 5 Q07812,P49327,P55210,O95831 4 |
| Fatty acid betaoxidation 0.4581156267514013 1.413585906081137 0.1574835218466117 1.0 0.5182869182374031 21 Q16836,P16219,P23786,O43772,Q9UKU0 5 |
| Nrf2 pathway 0.46479124864994 1.4049172706785715 0.1600458802871878 1.0 0.5182869182374031 20 P11413,Q14914,Q99735,Q9UPY5,P09601 5 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5800087771910453 1.3906428389170755 0.1643337590606997 1.0 0.5199510086462561 9 P07196,Q15907,Q9NR77 3 |
| Oxidation by cytochrome p450 0.6900797002819575 1.371633672225519 0.1701775060031525 1.0 0.522750390235325 5 Q16850,P16435,O43169 3 |
| Progeriaassociated lipodystrophy 0.5626900242829589 1.3508361138050482 0.1767479367853224 1.0 0.5282078220916051 10 O75844,O60725 2 |
| Proteasome degradation 0.3830990381325166 1.3469150090048294 0.1780076070388119 1.0 0.5282078220916051 41 Q9UNM6,P49720,O00231,O43242,P49721,Q9UL46,Q99436,P25788,P04439,P48556,P60900,P20618,P28070,P28072,P62191,P25787,O75832,P51665,P01889,P28074 20 |
| Relationship between inflammation cox2 and egfr 0.7247696970529223 1.344199131977577 0.1788840022924707 1.0 0.5282078220916051 4 P31751 1 |
| Glycogen synthesis and degradation 0.455277962408244 1.3344827854104 0.1820456848740392 1.0 0.5286626078496329 20 P63151,P52789,Q13362,P35573,P46976,Q93100 6 |
| Nrf2are regulation 0.6375063091983355 1.3313914358803531 0.183060245890505 1.0 0.5286626078496329 7 P09601,Q9UPY5 2 |
| Autophagy 0.6023561161703087 1.326354699827656 0.1847222362658436 1.0 0.5286626078496329 8 Q96B36,Q9NT62,Q99570,Q8NEB9 4 |
| Vitamin a and carotenoid metabolism 0.6763214609057554 1.310539880086646 0.1900132622329526 1.0 0.536877094705371 5 P29375 1 |
| Kallmann syndrome 0.7325793981927085 1.2773876152555328 0.2014654349661384 1.0 0.561292072301009 3 P28482 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5261510372730535 1.262660064012301 0.206711372028467 1.0 0.5732412585419062 12 P13674,O75718,O15460 3 |
| Adipogenesis 0.4698898669424296 1.2429782577526576 0.2138758455825011 1.0 0.5806139005469843 17 O75844,P14174,Q9NZ45,P43490 4 |
| Wnt signaling pathway 0.4993347629428259 1.2373783158461371 0.2159466652068657 1.0 0.5806139005469843 14 P28482,Q00534,O14641 3 |
| Hepatitis b infection 0.4211820338024341 1.2356198904826745 0.2165998876420958 1.0 0.5806139005469843 24 P40763,Q7Z434,Q16539,Q15904,Q9Y277,P49327,P42224,P62993,P28482,P31751 10 |
| Glycerolipids and glycerophospholipids 0.6591461056374073 1.2342107119355763 0.2171243968656502 1.0 0.5806139005469843 5 Q9HBU6 1 |
| Degradation pathway of sphingolipids including diseases 0.628306187888368 1.2233255534500926 0.2212067593337541 1.0 0.5889015504040832 6 P16278,P17900 2 |
| Amyotrophic lateral sclerosis als 0.5345633231005845 1.1959138004098395 0.2317301991304756 1.0 0.6043118601455212 10 Q16539,P20339,Q07812,Q9BUN8,P07196,Q08209 6 |
| Sarscov2 and covid19 pathway 0.7122557154594454 1.1938177849035587 0.2325492531485933 1.0 0.6043118601455212 3 Q8WTV0 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.711827956989243 1.192060700185861 0.2332374452305448 1.0 0.6043118601455212 3 Q16539,P55210 2 |
| Nitric oxide metabolism in cystic fibrosis 0.6883835279655823 1.1906307590466674 0.2337985709169374 1.0 0.6043118601455212 4 Q99873,O14744,Q86X55 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.709370199692776 1.1819670994965594 0.2372187556342795 1.0 0.6084285070189901 3 P40763,P31751 2 |
| Apoptosis modulation and signaling 0.4867139255524021 1.1585815212807231 0.2466268046724449 1.0 0.6145058619793511 14 O95817,O95831,P04632,Q07812,P49327,P55210,Q13546 7 |
| Mitochondrial complex i assembly model oxphos system 0.3928207245385308 1.149812408263691 0.2502211434929711 1.0 0.6159001984938718 29 O75306,Q8N183,Q9BUB7,Q96CU9,Q9Y6M9,O43676,P03886,O96000 8 |
| Methionine de novo and salvage pathway 0.5987512705817998 1.14820433267356 0.2508842210893234 1.0 0.6159001984938718 7 Q13126 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4935569034946542 1.1328444395720356 0.2572795856122898 1.0 0.6290223338031086 13 O75822,P60228,O00303,P55010 4 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6722718088072672 1.122761182399303 0.2615389355497355 1.0 0.6342583902602897 4 P09601,Q9UPY5 2 |
| Il10 antiinflammatory signaling pathway 0.6683311486071893 1.106189954021718 0.2686443101388502 1.0 0.6488626684402069 4 P09601,P42224 2 |
| Allograft rejection 0.5064130000118772 1.0907565373657448 0.2753800255941023 1.0 0.6541710235392337 11 P08670,P08183,Q9BY49,P10321,P04439,P49327,P42224,P55210,P01889 9 |
| Leptininsulin signaling overlap 0.6188574938574986 1.0885703318025386 0.276343405835632 1.0 0.6541710235392337 2 P40763 1 |
| Nad metabolism sirtuins and aging 0.6261596342235138 1.0878073620229722 0.2766801587910894 1.0 0.6541710235392337 5 P43490 1 |
| Apoptosis modulation by hsp70 0.6257944273917541 1.086190488514026 0.2773947245057853 1.0 0.6541710235392337 5 P49327,P55210,O95831 3 |
| Nuclear receptors metapathway 0.3530786683824896 1.0813418148213585 0.2795450935689809 1.0 0.6566569060698807 45 P11413,P48507,P08183,Q14914,Q99735,Q9UPY5,P23786,Q15067,P09601 9 |
| Il7 signaling pathway 0.5881570433609853 1.0381752489681848 0.2991884735205659 1.0 0.6946275024760424 6 P28482,P42224 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6713306951830351 1.026426765124972 0.3046904673332093 1.0 0.70077540342567 3 Q9BXK5 1 |
| Physiological and pathological hypertrophy of the heart 0.5330570857945492 0.9784661386396782 0.3278438307880167 1.0 0.7273276097852668 8 P40763,P28482,Q16539,Q08209 4 |
| Ccl18 signaling pathway 0.4920862657911818 0.9619685908373368 0.3360653816963848 1.0 0.7373742257733864 10 P08670,P42224,Q86UE4,P07196,P00403 5 |
| Angiogenesis 0.6545320698963896 0.9583750555062042 0.337873668952918 1.0 0.7382559244568508 3 P28482 1 |
| Il2 signaling pathway 0.4910481535684117 0.956277239799438 0.3389321856855325 1.0 0.7382559244568508 10 P62993,P28482,O43524,P42224 4 |
| Dna mismatch repair 0.4039118471789208 0.9524415109048556 0.3408731155397611 1.0 0.7397934645228873 20 Q9UQ84,P15927,P49005,P35244 4 |
| Immune response to tuberculosis 0.6452745726400153 0.921115824319918 0.3569899593211638 1.0 0.7664408087217818 3 Q03518 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.5574682541557433 0.8979113185784253 0.3692328299139518 1.0 0.7870835057596338 6 P31751 1 |
| Ppar signaling pathway 0.4092849359352194 0.8854266480198939 0.3759265652530006 1.0 0.7930471947822504 18 Q9UKU0,P23786 2 |
| Tryptophan metabolism 0.4302062264893292 0.8694529211303826 0.3845994478617753 1.0 0.8027005897881654 15 P05091,Q16836,Q15392,P51648 4 |
| Bile acids synthesis and enterohepatic circulation 0.6315816363721021 0.86639335257956 0.3862744880784516 1.0 0.8033972859687241 3 P28482 1 |
| Praderwilli and angelman syndrome 0.5366907753494475 0.8568823898296736 0.3915098861032966 1.0 0.8114685874597739 7 Q05086,Q00534,P11802 3 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6264208909370139 0.8459061854521641 0.3976050816218635 1.0 0.821260151349987 3 P40763,P28482 2 |
| Pilocytic astrocytoma 0.6246790357614151 0.8390099376624492 0.4014637330231534 1.0 0.8240127545812754 3 P62993 1 |
| Cancer immunotherapy by pd1 blockade 0.6245775729646637 0.8386085302416607 0.4016890222666651 1.0 0.8240127545812754 3 P40763,P04439 2 |
| Embryonic stem cell pluripotency pathways 0.4437960228781027 0.833699933698828 0.4044500955087244 1.0 0.8268450758011124 13 P62993,P28482,P31751 3 |
| G1 to s cell cycle control 0.3636623079273502 0.8154865351348731 0.4147938688649359 1.0 0.8356584996615015 26 P15927,P11802,Q9Y619,P35244 4 |
| Angiopoietinlike protein 8 regulatory pathway 0.3493952865302623 0.7948554587954906 0.4266975863130047 1.0 0.8423933477830992 30 P41440,Q16539,Q9UPT5,Q8NEB9,Q99570,P49327,P28482,P31751,O43524,Q15382 10 |
| Glioblastoma signaling pathways 0.3947163376994879 0.7840575024259417 0.4330063702675424 1.0 0.8476170450662024 18 P11802,P62993,P28482,P31751,O43524 5 |
| Heme biosynthesis 0.5526577566030582 0.7674055279094207 0.4428404428856594 1.0 0.8584512145259221 5 P36551 1 |
| 7oxoc and 7betahc pathways 0.455607674274627 0.7638364618230817 0.4449647052828722 1.0 0.8588724666591996 10 Q9UBM7 1 |
| Il17 signaling pathway 0.585020720104579 0.7622254860085504 0.4459254376143757 1.0 0.8588724666591996 4 P40763,P28482 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3972695548339047 0.7490316075367917 0.4538381549545822 1.0 0.8705951837499167 17 Q14739,O94901,P62993,P28482,P42167,P50402 6 |
| Serotonin and anxiety 0.5944700460829425 0.7211561761540437 0.470813431355144 1.0 0.8868466835903498 3 Q06787,Q08209 2 |
| Mapk pathway in congenital thyroid cancer 0.5331695331695429 0.7079629295653442 0.478968278541217 1.0 0.894081796489378 2 P27361 1 |
| Osteoblast differentiation and related diseases 0.4258783773064949 0.6816389313863577 0.4954672913215809 1.0 0.907326302122949 12 P28482,Q16539,Q8NEB9,P42224 4 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.432789934394613 0.6789720564296905 0.4971555676160815 1.0 0.907326302122949 11 P28482,Q05086,Q15382,P31751 4 |
| Mapk cascade 0.5034796039261966 0.6580277045131336 0.5105203291180442 1.0 0.9183233547799056 6 P62993,P28482 2 |
| Neural crest cell migration during development 0.4923280384159343 0.6102565129231857 0.541691899169614 1.0 0.9487527707678328 6 P40763,P61586,P31751,Q99570 4 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3856182787801213 0.5898147845550329 0.5553148296149217 1.0 0.9542904899307828 15 P11413,P43490 2 |
| Il9 signaling pathway 0.4723220779628823 0.5674457937363667 0.570411344797952 1.0 0.9650697239114172 7 P62993,P28482,P42224 3 |
| Cardiac hypertrophic response 0.4091272130271981 0.5525506022456893 0.5805711752396583 1.0 0.9733093070953514 11 P28482,P31751,Q08209 3 |
| Imatinib and chronic myeloid leukemia 0.5468840071612218 0.5446182232835489 0.5860161186943009 1.0 0.9733093070953514 3 P08183 1 |
| Mitochondrial immune response to sarscov2 0.4188652100645892 0.5429260712952556 0.5871807045952346 1.0 0.9733093070953514 9 Q9BQ95,Q7Z434,Q9Y6M9,O94826 4 |
| Glycerophospholipid biosynthetic pathway 0.4750312938636992 0.5378571027251006 0.5906757057804599 1.0 0.9733093070953514 6 Q9BTU6,O00116 2 |
| Thermogenesis 0.3240371149084146 0.5375680909499763 0.5908752645262585 1.0 0.9733093070953514 28 O43772,Q9UKU0,P23786 3 |
| Resistin as a regulator of inflammation 0.4730566169327219 0.5297389213663403 0.5962929583819938 1.0 0.9763211083871608 6 P28482,P31751 2 |
| Neural crest cell migration in cancer 0.4387310147361973 0.5238167342801082 0.6004060130163473 1.0 0.9772913092304132 8 P40763,P61586,Q99570,P31751,Q99523 5 |
| Endometrial cancer 0.3816319205630695 0.5177044626570748 0.6046644841378894 1.0 0.9815556260124548 14 P28482,P31751,O43524 3 |
| Tolllike receptor signaling pathway 0.3991101204314163 0.5006073877883652 0.6166474620532809 1.0 0.9876252132885436 11 P28482,P31751,Q16539,P42224 4 |
| Aryl hydrocarbon receptor pathway wp2873 0.5134602380296738 0.4888954456307964 0.6249157202294033 1.0 0.9955439266420548 4 Q16543 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4584290372470379 0.4706639933795613 0.6378807011134953 1.0 1.0 6 P28482 1 |
| Camkk2 pathway 0.3799908750116875 0.4678968167422201 0.6398583800151698 1.0 1.0 13 P09601,O76024 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.5232541621038267 0.4626925785359097 0.6435847386467559 1.0 1.0 3 P42224 1 |
| Egfr tyrosine kinase inhibitor resistance 0.3461489648167677 0.4588391825055967 0.6463496550675965 1.0 1.0 18 P40763,P62993,P28482,P31751,O43524,P21359 6 |
| Pdgfrbeta pathway 0.4153846153846293 0.4209151462028354 0.6738170447575589 1.0 1.0 8 P40763,P27361,P05771,P19174,P42224,P62993,Q02750 7 |
| Neuroinflammation 0.4916623708843676 0.4130748721645179 0.6795517588730313 1.0 1.0 4 P00403 1 |
| Bmp signaling in eyelid development 0.4530098280098326 0.3947069567195968 0.6930591680716245 1.0 1.0 2 P27361 1 |
| Hippoyap signaling pathway 0.4517813267813283 0.3904481763947666 0.696205169459486 1.0 1.0 2 Q13043 1 |
| Dna replication 0.3002768273335947 0.3851766411009069 0.70010654845279 1.0 1.0 30 P41440,Q9Y619,P35244,P09884,P49643,O75419,P15927,P49005,P56282 9 |
| Translation factors 0.2907789033866648 0.3835759647483506 0.7012927571418508 1.0 1.0 35 P55010,O15372,Q14240,O75822,P60228,O00303,Q15056,O75153 8 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4546572394712728 0.3808618414446746 0.703305768387493 1.0 1.0 5 P48729,P49841,P35222,O14641 4 |
| Phosphoinositides metabolism 0.4038953025827186 0.3725888233946355 0.7094544924714261 1.0 1.0 8 Q8TBX8 1 |
| Fluoroacetic acid toxicity 0.451585136240234 0.3701184722647129 0.7112942190475866 1.0 1.0 5 P51648 1 |
| Tgfbeta receptor signaling 0.431426814268149 0.367295061570938 0.7133989373611285 1.0 1.0 6 P40763,P27361,P35222,P42224,P45984 5 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.431426814268149 0.367295061570938 0.7133989373611285 1.0 1.0 6 P40763,P27361,P35222,P42224,P45984 5 |
| Pdgf pathway 0.3600268735549576 0.3627111329827853 0.7168206823744507 1.0 1.0 13 P62993,P28482,P00403,P42224 4 |
| Oxidative phosphorylation 0.2938351642294568 0.3355569948328231 0.737204958496199 1.0 1.0 30 P24539,O75964,O75306,Q86Y39,P03886,O96000 6 |
| Nucleotide metabolism 0.3469329652035479 0.3275610129035932 0.7432436040839414 1.0 1.0 14 P54098,Q7LG56,P09884,P31350 4 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4197218553998826 0.3251715827909994 0.7450512146529378 1.0 1.0 6 P28482,Q16539 2 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3514145034670085 0.3194075435385728 0.7494174912716414 1.0 1.0 13 Q86UE4,O14641 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2914913215829811 0.3178428897649344 0.7506041150455702 1.0 1.0 30 P37268,Q9NR31,Q16850,Q8WTV0 4 |
| Interactions between loxl4 and oxidative stress pathway 0.4610548305658718 0.3147971693219725 0.7529156611058374 1.0 1.0 4 Q8TAG9,Q16543 2 |
| Wnt signaling in kidney disease 0.4532882606023385 0.2915988222208104 0.7705933760495227 1.0 1.0 4 P61586,P35222,O14641 3 |
| Follicle stimulating hormone fsh signaling pathway 0.4014023007270166 0.2867256374759684 0.774322405571712 1.0 1.0 7 P28482,Q16539 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.4008198124742939 0.2846775915332901 0.7758911599588236 1.0 1.0 7 Q16543,P28482,P21359 3 |
| Nonsmall cell lung cancer 0.3169603350809217 0.281096544747142 0.7786363512650942 1.0 1.0 18 P11802,P62993,P28482,P31751,O43524 5 |
| Urea cycle and metabolism of amino groups 0.3802875654292162 0.2791068863653428 0.7801627984997703 1.0 1.0 8 P78540 1 |
| 15q112 copy number variation syndrome 0.448678549477569 0.2781917097763773 0.7808651984275974 1.0 1.0 4 Q7L576,Q9BSJ2,Q06787 3 |
| Onecarbon metabolism and related pathways 0.3410090767465248 0.2690323643279194 0.7879047773668351 1.0 1.0 13 O43865,P35790,Q9HBU6 3 |
| Joubert syndrome 0.3126805385587391 0.2567305417910401 0.797386792623209 1.0 1.0 18 Q13432 1 |
| Nanoparticle triggered regulated necrosis 0.4069410319410326 0.2500851311457381 0.8025215143351956 1.0 1.0 2 Q13546 1 |
| Nanoparticlemediated activation of receptor signaling 0.3884201456340068 0.2423164404962646 0.8085349756472002 1.0 1.0 7 P62993,P28482 2 |
| Micrornas in cardiomyocyte hypertrophy 0.303820466184276 0.2373108921614056 0.8124156127050206 1.0 1.0 19 P40763,Q16539,P28482,P31751,Q08209 5 |
| Cellular proteostasis 0.4314256860691964 0.2305273026766848 0.8176820502547761 1.0 1.0 4 P61758,Q99471 2 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3798185085202678 0.2143849401021032 0.830246884719668 1.0 1.0 7 P31751 1 |
| Il4 signaling pathway 0.3443431728095734 0.2142863619782467 0.8303237526017262 1.0 1.0 9 P62993,P28482,Q16539,P42224 4 |
| Epo receptor signaling 0.379243523728387 0.212562203586908 0.8316684548465612 1.0 1.0 7 P62993,P28482,P42224 3 |
| Dna damage response only atm dependent 0.2864113780969762 0.2121343886060376 0.8320021919458256 1.0 1.0 24 Q8NEB9,P62993,P28482,P31751,O43524,Q13362 6 |
| Network map of sarscov2 signaling pathway 0.2833296787359697 0.209548349267295 0.834020195800542 1.0 1.0 26 Q9H269,Q7Z434,P31350,P07858,Q96AX1,Q14240,P42224,Q96J02,Q86VN1,Q9P253,Q15382 11 |
| Riboflavin and coq disorders 0.378667429268691 0.1931021977977594 0.8468789314583605 1.0 1.0 6 Q8NI60,Q16134 2 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3261300747876585 0.1825813458239262 0.855126522168818 1.0 1.0 12 P28482,P31751,Q16539,P55210 4 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3728348540426819 0.1765635314965284 0.8598512416096751 1.0 1.0 6 Q7Z434,Q16539,P42224 3 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.4092904721739371 0.1755596722517617 0.8606398870638112 1.0 1.0 4 P28482 1 |
| Erk pathway in huntingtons disease 0.4034114957583378 0.1621899852134381 0.871156246025732 1.0 1.0 4 P28482 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3797982842738228 0.1557986208146075 0.8761917577814144 1.0 1.0 5 P28482 1 |
| Hepatitis c and hepatocellular carcinoma 0.3255870394162064 0.1551472009140439 0.8767052717131423 1.0 1.0 10 P62993,Q16539,P31350,P55210 4 |
| Glycosylation and related congenital defects 0.3188366413366372 0.1534448334511014 0.8780474915077798 1.0 1.0 12 Q2TAA5,Q9BT22,Q9H3H5 3 |
| Leukocyteintrinsic hippo pathway functions 0.3565760106985902 0.1453886504714448 0.8844040250657512 1.0 1.0 7 Q13043,Q16539,O43524 3 |
| Vitamin d in inflammatory diseases 0.3950019676181001 0.1439892780252688 0.8855089363021329 1.0 1.0 4 Q08209 1 |
| Retinoblastoma gene in cancer 0.2551238057911691 0.1237283699551987 0.9015303482746496 1.0 1.0 47 P11802,P33981,P35244,P09429,Q9Y619,P09884,O75419,P15927,Q00534,P26583,Q16204,Q14527 12 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3085905879066153 0.1148776792590173 0.9085420773201508 1.0 1.0 12 P28482,Q9BTU6,Q16539,P42224 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3110697135556659 0.1010313047750038 0.9195256096937484 1.0 1.0 9 P31943 1 |
| Cysteine and methionine catabolism 0.3470642483861162 0.0856201099565703 0.9317684117287136 1.0 1.0 5 P23526,P25325,P48637,Q99707 4 |
| Regulation of actin cytoskeleton 0.2506575101110965 0.0848437634781837 0.9323856007264306 1.0 1.0 37 Q8TBX8,Q9UQB8 2 |
| Il6 signaling pathway 0.3017691233387638 0.0825995750843097 0.9341699391556596 1.0 1.0 11 P62993,P28482,P42224 3 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3435041069876779 0.079120900276521 0.9369364596083718 1.0 1.0 5 O43524 1 |
| Il5 signaling pathway 0.2951239333316478 0.0686474175802808 0.9452702740921132 1.0 1.0 12 P62993,P28482,O43524,P42224 4 |
| Omega9 fatty acid synthesis 0.3265682656826612 0.0675236406361498 0.946164842465719 1.0 1.0 6 O95864,O00767,P49327,O95573,P33121 5 |
| Alpha 6 beta 4 signaling pathway 0.2981550832006908 0.066643029104081 0.946865889595657 1.0 1.0 10 P62993,P28482 2 |
| Physicochemical features and toxicityassociated pathways 0.283168053191361 0.0617884977185517 0.9507312634765244 1.0 1.0 15 P28482,P07196 2 |
| Copper homeostasis 0.3098323278224163 0.0609373903861065 0.951409071541284 1.0 1.0 8 O75880,O43524 2 |
| Interferon type i signaling pathways 0.2779148673658203 0.0519005817958631 0.9586079106962986 1.0 1.0 16 P40763,Q16539,P63000,Q06124,Q99873,P46108,P60842,P42224,P16220,P06730,P23588,P46109,P63244,P42345,Q53EL6 15 |
| Bladder cancer 0.311426295919736 0.0406764936518897 0.9675538014305748 1.0 1.0 6 P28482 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.3091206641051507 0.0368582682599631 0.9705980142242514 1.0 1.0 7 Q9P0J0,Q7L5N1 2 |
| Transsulfuration pathway 0.3075976622577622 0.0341235552753282 0.9727786250273468 1.0 1.0 7 P25325,P48507,P23526,P17174,P26358,Q99707 6 |
| Vitamin b12 disorders 0.3118279569892382 0.0271337123609141 0.9783530860772334 1.0 1.0 3 Q96EY8,Q99707 2 |
| Inclusion body myositis 0.3050691244239537 0.0229322444104008 0.9817043198337044 1.0 1.0 3 P05067,Q92542 2 |
| Disruption of postsynaptic signaling by cnv 0.2809406704226954 0.0219712139076371 0.9824709179670283 1.0 1.0 9 Q14168 1 |
| Hedgehog signaling pathway wp4249 0.2992319508448443 0.0196672385070721 0.9843088256065168 1.0 1.0 3 P48729,Q9Y496 2 |
| Estrogen signaling pathway 0.2972349675090844 0.0194125959641931 0.984511962176132 1.0 1.0 6 P28482 1 |
| Breast cancer pathway 0.2509294084987172 0.0173974327044331 0.98611955725153 1.0 1.0 24 O14641,P11802,P62993,P28482,P31751 5 |
| Hepatocyte growth factor receptor signaling 0.2787184427361511 0.0170713860375885 0.9863796662196702 1.0 1.0 9 P62993,P28482 2 |
| 15q133 copy number variation syndrome 0.2927803379416197 0.0164268563286216 0.9868938543860865 1.0 1.0 3 Q9BXW9,Q16658 2 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2853142839319528 0.0103832003355873 0.9917155536196458 1.0 1.0 8 Q8IXH7,Q08209 2 |
| Tcell receptor tcr signaling pathway 0.2639528355012995 0.0102613169862829 0.991812797281468 1.0 1.0 17 P62993,P28482,P08670,Q16539 4 |
| Mammary gland development pathway involution stage 4 of 4 0.2771274417625725 0.010017786847332 0.9920070962307028 1.0 1.0 3 P40763 1 |
| Regulatory circuits of the stat3 signaling pathway 0.2760520624114986 0.0098970350561366 0.9921034374442927 1.0 1.0 10 P40763,P28482,Q16539 3 |
| Intraflagellar transport proteins binding to dynein 0.2849624335381125 0.0097567907948071 0.992215330772257 1.0 1.0 8 Q9BW83,O43237,Q9Y6G9 3 |
| Head and neck squamous cell carcinoma 0.2723354599821286 0.0064348846410978 0.9948657403273602 1.0 1.0 13 P31751,Q00534,P11802 3 |
| Mirna regulation of prostate cancer signaling pathways 0.2828811403182419 0.0061078368670163 0.9951266815643264 1.0 1.0 8 P28482 1 |
| Serotonin htr1 group and fos pathway 0.2809230769230665 0.0027627129862986 0.9977956767664165 1.0 1.0 8 P27361,Q16539,P61586,P28482,Q02750,P16220,P63096 7 |
|
|
